Talk One: Uptake, Adherence, and Outcomes with low-dose Tamoxifen at Mayo Clinic Rochester Uptake, Adherence, and Outcomes with low-dose Tamoxifen at Mayo Clinic Rochester
Presenter: Christine Klassen, MD

Talk Two: Breast Cancer in the Context of Spontaneous Coronary Artery Dissection (SCAD)
Presenters: Susan Kok, MD, and Ashley E. Battenberg, MS

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to: 

1. Review the data regarding use of low-dose Tamoxifen for breast cancer risk reduction
2. Summarize the outcomes of our low-dose Tamoxifen experience at Mayo Clinic
3. Detect difference in patient populations who may be better candidates for low-dose Tamoxifen

       1. List two challenges of treating breast cancer in patients with a history of SCAD
       2. Describe the importance of a multidisciplinary approach to patients with breast cancer after SCAD

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity.  This course is not approved for on-demand delivery. 

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.